🇺🇸 Discontinuation of β-blocker in United States

Discontinuation of β-blocker (Discontinuation of β-blocker) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Discontinuation of β-blocker in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Discontinuation of β-blocker approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Discontinuation of β-blocker in United States?

Samsung Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.